Breast cancer DNA test could save the NHS £4m a year - and spare younger women chemotherapy
Full story
Expanding the availability of genetic testing for breast cancer could reduce NHS spending by £4m annually. This change would also benefit thousands of patients by preventing the side effects associated with chemotherapy. Younger women would be particularly spared from these treatments.
Making genetic testing more widely available could save the NHS £4m a year - and spare thousands of breast cancer patients the debilitating side effects of chemotherapy.